Clearer Medication Instructions for Patients with Limited English
Addressing health literacy barriers in medication instructions for patients with low English proficiency is a routine patient-safety task, not an optional extra. A label such as “take one tablet twice daily” may look simple to a pharmacist yet still be misunderstood when it combines unfamiliar words, numerals, timing instructions and an unfamiliar medicine. The result can be a missed dose, doubled dose, wrong route or premature cessation.
Health literacy extends beyond reading English. It includes understanding labels, estimating quantities, recognising urgency, navigating the health system and deciding when advice needs clarification. Some patients read English well but have limited health vocabulary; others understand spoken English but not written directions. People who use languages other than English at home, Deaf people who use Auslan and carers managing medicines for family members may need different supports.
Australia makes this visible in everyday practice. In the 2021 Census, 27.4% of people reported using a language other than English at home, and major cities such as Sydney, Melbourne, Adelaide and Brisbane contain many culturally and linguistically diverse communities. Community pharmacies often sit in busy shopping strips near public transport and serve as one of the easiest health services to enter without an appointment. This makes pharmacists well placed to identify problems hidden in rushed medical consultations.
Safe communication is also part of lawful, respectful care. The Privacy Act 1988, Australian Privacy Principles and applicable state and territory health-records laws protect patient information, while professional standards support informed consent and privacy when interpreters are involved. Therapeutic Goods Administration requirements and inclusion in the Australian Register of Therapeutic Goods govern the supply of medicines, but compliant labelling does not guarantee that every patient can interpret the directions. The pharmacist remains responsible for the final safety check.
Start with the patient, not a language assumption
Ask which language the patient prefers for everyday conversation and for medicines. Record spoken and written preferences, and ask whether they need an interpreter, accessible information or help with numbers. A simple, private question—“Which language would you like us to use?”—avoids assumptions based on appearance or surname. Health literacy needs should be treated as clinical information and reviewed whenever circumstances change.
Then explore the medicine routine rather than delivering a script. Ask what the patient already takes, when it is easiest to take a dose, and whether work shifts, fasting, caring duties or traditional remedies affect treatment. A morning dose may need to be tied to breakfast, while a night dose may be linked to a caregiver’s routine. This practical context can prevent confusion that a translated leaflet alone would not resolve.
Make interpreter support routine
Use a qualified interpreter for consent, medication histories, dose changes and high-risk counselling. Family members, especially children, should not interpret clinical details or consent because they may filter information or carry a conflict of interest. Public hospitals and community health services generally provide free interpreters, while pharmacies can arrange telephone or video interpreting through booked services. Deaf patients may need an accredited Auslan interpreter rather than an oral-language interpreter.
Interpreters should work under confidentiality obligations, and pharmacists should explain that role before counselling begins. Document the language used, interpreter identity and any interpretation-dependent decisions in the medication record. The value of treating counselling as a two-way process is reinforced by Johnathan Laird’s guidance: the pharmacist checks meaning and understanding, while the interpreter supports accurate communication.
Turn clinical directions into usable actions
Replace clinical shorthand with one action at a time. Instead of “take one tablet twice daily after food if required for nausea,” give separate directions: “Take 1 tablet in the morning. Take 1 tablet at night. Take it after you eat. If you feel sick and have not taken it, call the pharmacy for advice.” Include what to take, how much, when, route, food or fluid requirements, missed-dose actions and urgent warnings. Use clear numerals and anchor doses to daily events rather than vague intervals.
Written aids should reinforce, not replace, spoken counselling. Provide large-print English, professionally translated material and clear pictograms, while keeping the medicine’s official label and warnings visible. Machine translation can alter dose, route or warnings, so every document needs clinical checking. For specialised routes, wording can be adapted from buccal medicine instructions, provided the pharmacist verifies it against the approved product information.
Australian product information approved through the Therapeutic Goods Administration can be lengthy and professionally written. A concise pharmacy-prepared instruction sheet can sit beside it without covering warnings or altering manufacturer packaging. For medicines such as insulin, inhalers, eye drops and liquid antibiotics, demonstrate the device separately and identify the exact measuring tool required.
Check understanding without shame
Teach-back checks the clarity of the explanation rather than testing the patient. Ask, “So I know I explained this clearly, can you show me how you will take it at home?” Invite the patient to describe the dose, time, route and next step, or to demonstrate the task. Correct gaps immediately, then explain that section again in a different way. The goal is a safe plan, not a right answer spoken back under pressure.
Include numeracy, dexterity and access in the check. A person may understand “5 mL” but lack the vision, strength or equipment to measure it; use a marked oral syringe rather than a household teaspoon. Show how an inhaler, insulin pen, eye-drop bottle or patch is opened and used, and ask whether the patient can obtain the next supply. If a carer will assist, confirm the patient’s consent and include the carer in the demonstration. Document what was explained and what action is planned if understanding remains uncertain.
Build multilingual care into the team workflow
Share the patient’s language preference, interpreter requirement and active medication list with general practitioners, hospitals, aged-care teams and other pharmacists. In a fragmented system, a discharge summary written only in English can lose essential context, especially when a patient moves from a metropolitan hospital to a community pharmacy or regional service. A shared, plain-language medication plan should identify what changed, why it changed and what must be monitored.
Equip the dispensary with approved translated resources, telephone interpreting, large-print templates and staff trained to document language needs. Digital instructions and SMS reminders can reinforce the plan, but not every patient has reliable connectivity, a suitable device or the ability to use an app, so printable and telephone options must remain available. The Pharmaceutical Benefits Scheme affects what patients pay, but a low co-payment does not remove language or comprehension barriers.
Give priority to medicines with narrow therapeutic margins, complex schedules or serious consequences from error, including insulin, anticoagulants, opioids and medicines requiring precise measurement. Ask the patient to repeat the plan at the end of the dispensing conversation and arrange a follow-up contact for complex changes. A language preference recorded in the dispensing system should trigger support whenever the patient returns, rather than being treated as a one-time note.
Compare support methods and use a consistent protocol
No single tool resolves every barrier. Plain English helps many readers but cannot replace an interpreter for detailed consent; pictograms support routine actions but cannot carry every warning; digital resources can reinforce timing but may exclude patients with limited access. The most reliable approach combines professional interpreting, concise instructions, demonstration and teach-back, then documents the result in the patient record.
| Method | Best use | Important limitation | Practical application in Australia |
|---|---|---|---|
| Plain-English instructions | Quick, written directions | May not meet language needs | Keep each instruction to one action and use exact doses |
| Professional interpreter | Consent, history and complex counselling | Requires booking or connection | Use telephone or video interpreting and document it |
| Translated information | Written reinforcement | Quality and readability vary | Use professionally reviewed, medicine-specific material |
| Teach-back | Checking what the patient will do | Takes time and sensitive phrasing | Ask the patient to explain or demonstrate the plan |
| Pictograms and devices | Showing routes and measuring steps | Images may be ambiguous | Pair with words and verify manufacturer directions |
| Digital reminders | Reinforcement between visits | Digital exclusion and privacy risks | Offer SMS, print and telephone alternatives |
A consistent protocol should combine these methods according to clinical risk, language preference and the patient’s needs. Pharmacists should use the following steps for every medicine that could cause harm if misunderstood:
- Record the patient’s preferred spoken and written language, interpreter needs and communication preferences in the medication profile.
- Arrange a qualified interpreter before discussing consent, a dose change or a high-risk medicine, and avoid relying on family members.
- Give a short medicine-specific plan covering the dose, time, route, food or fluid requirements, missed doses and urgent warning signs.
- Use teach-back and, where appropriate, ask the patient to demonstrate how they will use the device or measure the dose.
- Provide professionally reviewed translated or large-print information alongside the official label, without covering warnings or changing the packaging.
- Review language support at each dispensing visit and audit whether high-risk patients receive an interpreter and an understood follow-up plan.
Make the next medicine conversation safer
For pharmacists and pharmacy teams, make language support part of the workflow before the next medicine is handed over. Add a preferred-language field to the patient record, keep the telephone interpreter number accessible at the counter, and agree which documents require professional review. Build the extra few minutes needed for high-risk counselling into rosters and clinical workflow rather than expecting every pharmacist to improvise alone.
For patients and carers, bring the medicine package, a current medicine list and an interpreter to the pharmacy when instructions seem unclear. Ask for the medicine’s name, purpose, dose, timing and missed-dose plan in writing, and request a demonstration with the actual device. Speak with your pharmacist or interpreter-supported service before the next dose and leave the consultation with a plan you can follow.